发明名称 COMBINED USE OF MEDICATION FOR ALLEVIATING FORMATION OF SCAR TISSUE
摘要 <P>PROBLEM TO BE SOLVED: To provide devices and methods for preventing formation of scar tissues and/or adhesion subsequent to surgical treatment, an injury, or a wound. <P>SOLUTION: The invention includes various devices and methods, in which antiproliferative chemical having cytostatic performance is provided between internal tissues solely or with other medicine for preventing formation of scar tissues and/or adhesion during treatment of a wound or other surgical part. The devices for achieving above dosage include permanent implant or biolytic material including antiproliferative chemical such as sirolimus attached to it, but they are not limited to these. The antiproliferative chemical includes antiplatelet agent, antithrombotic agent, or anticoagulant agent, and may be used with other chemical that is not limited to them. The methods for alleviating formation of scar tissues and/or adhesion, or adhesion at an inosculation part are also provided. The antiproliferative chemical having cytostatic performance is dosed for arteriovenous shunt inosculation to a patient of an end-stage renal disease. <P>COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009022759(A) 申请公布日期 2009.02.05
申请号 JP20080184851 申请日期 2008.07.16
申请人 AFMEDICA INC 发明人 SHEBUSKI ROLAND J;LUDERER JACK R;FISCHELL TIM A
分类号 A61L29/00;A61B17/00;A61B17/06;A61B17/064;A61F13/00;A61K31/167;A61K31/436;A61K38/00;A61K45/00;A61K47/32;A61L15/44;A61L27/00;A61L27/54;A61L31/00;A61L31/16;A61P41/00;A61P43/00 主分类号 A61L29/00
代理机构 代理人
主权项
地址